NIMH Study on Adolescent Depression Aims to Enhance Treatment Understanding
The NIMH is conducting a study to explore causes and treatments for depression in adolescents aged 11-17, comparing those with and without mental health diagnoses.
Phase III
Mental Health / Depression
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This NIMH study aims to enhance understanding of adolescent depression, which is crucial for developing effective treatments in this demographic. Insights gained could significantly influence the strategies of pharmaceutical companies targeting mental health, particularly in adolescent populations.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor recruitment progress and initial findings related to treatment efficacy and brain changes in participants over the study duration.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.